|Articles|September 29, 2015

PRA Collaborates on Vaccine Studies

PRA Health Sciences (PRA) announced a collaboration with the Alliance for Multispecialty Research (AMR) to improve the efficiency of vaccine studies. AMR is a network of independently owned, geographically diverse, and experienced Clinical Research Centers of Excellence and along with PRA’s vaccine experience in Phase I-IV trials will facilitate identification of appropriate vaccine study populations, as well as address subject retention and trial conduct in this area.
Read the full release.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.